Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis.

Moying LiTimo ItzelNathally Espinosa MontagutThomas FalconerJimmy DazaJimyung ParkJae Youn CheongRae Woong ParkIsabella WiestMatthias Philip EbertGeorge HripcsakAndreas Teufel

Published in: Scandinavian journal of gastroenterology (2023)

Concomitant cardiovascular medications are associated with distinct survival difference in cirrhotic patients. Multidisciplinary management is needed for a judicious choice of proper cardiovascular co-medications in cirrhotic patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed